SC 13G/A | 2023-10-05 | Sorrento Therapeutics, Inc. | Celularity Inc | 5,050,427 | 2.6% | EDGAR |
SC 13D/A | 2023-09-26 | Sorrento Therapeutics, Inc. | Scilex Holding Co | 1,917,210 | 1.3% | EDGAR |
SC 13D/A | 2023-08-15 | Sorrento Therapeutics, Inc. | Scilex Holding Co | 95,533,509 | 43.3% | EDGAR |
SC 13G/A | 2023-03-10 | STATE STREET CORP | Sorrento Therapeutics, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2023-03-08 | BlackRock Inc. | Sorrento Therapeutics, Inc. | 75,749 | 0.0% | EDGAR |
SC 13D/A | 2023-03-03 | Sorrento Therapeutics, Inc. | Scilex Holding Co | 95,533,509 | 44.2% | EDGAR |
SC 13G | 2023-02-17 | ICS OPPORTUNITIES, LTD. | Sorrento Therapeutics, Inc. | 11,376,140 | 2.4% | EDGAR |
SC 13G/A | 2023-02-09 | STATE STREET CORP | Sorrento Therapeutics, Inc. | - | 10.7% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Sorrento Therapeutics, Inc. | 29,535,954 | 6.3% | EDGAR |
SC 13G/A | 2023-02-03 | BlackRock Inc. | Sorrento Therapeutics, Inc. | 39,423,641 | 8.4% | EDGAR |
SC 13D/A | 2023-01-23 | Sorrento Therapeutics, Inc. | Scilex Holding Co | 95,533,509 | 45.5% | EDGAR |
SC 13D | 2022-11-17 | Sorrento Therapeutics, Inc. | Scilex Holding Company/DE | 167,887,687 | 96.3% | EDGAR |
SC 13G | 2022-07-11 | STATE STREET CORP | Sorrento Therapeutics, Inc. | - | 10.2% | EDGAR |
SC 13G | 2022-02-10 | VANGUARD GROUP INC | Sorrento Therapeutics, Inc. | 15,692,730 | 5.1% | EDGAR |
SC 13G/A | 2022-02-07 | BlackRock Inc. | Sorrento Therapeutics, Inc. | 21,775,865 | 6.9% | EDGAR |
SC 13G | 2021-07-23 | Sorrento Therapeutics, Inc. | Celularity Inc | 20,422,124 | 16.7% | EDGAR |
SC 13G | 2021-02-02 | BlackRock Inc. | Sorrento Therapeutics, Inc. | 17,619,678 | 6.7% | EDGAR |
SC 13G/A | 2021-02-01 | China In Shine Investment Ltd | Sorrento Therapeutics, Inc. | 4,760,801 | 1.8% | EDGAR |
SC 13G/A | 2021-02-01 | Hongguo International Holdings Ltd | Sorrento Therapeutics, Inc. | 4,074,000 | 1.5% | EDGAR |
SC 13G/A | 2021-02-01 | Top Path Asia Ltd | Sorrento Therapeutics, Inc. | 0 | - | EDGAR |